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Private Insurance Limits and 
Responses
SUMMARY. The COVID-19 pandemic exposed a number of existing flaws in the United States’ patchwork 
approach to paying for and providing access to medical care. Shelter-in-place orders, social distancing, and 
other public health strategies employed to address the pandemic spawned a global recession, causing rapid 
and high unemployment rates in many countries. The U.S. unemployment rate peaked in April 2020 at 14.7%, 
higher than in any previous period since World War II. The United States has long hewed an anachronistic 
policy of relying heavily on private employers to provide health insurance to a substantial portion of the 
population. Those who are not eligible for employer-sponsored insurance (ESI) must fend for themselves 
in the non-group market, unless they qualify for government-sponsored insurance or safety net programs. 
Companion Chapters in this volume describe the COVID-related challenges for Medicaid and the uninsured, 
while this Chapter focuses on the private insurance market. The Patient Protection and Affordable Care Act 
of 2010 (ACA) dramatically overhauled health insurance in the United States. But those reforms have been 
under continuous threat of dilution or wholesale repeal, including a case currently pending before the U.S. 
Supreme Court that could strike down the entire Act. Thus, any evaluation of the benefits or demerits of the 
private insurance market must be read against the possibility that existing consumer protections could be 
eliminated with the stroke of a pen.
Elizabeth Weeks, JD, University of Georgia School of Law
Introduction
The ACA enacted a comprehensive strategy to extend health 
insurance to more than 20 million previously uninsured individuals 
and families in the United States. Even at the time of enactment, 
many viewed the ACA as a fragile compromise and second-best 
solution to U.S. health care fragmentation. The COVID-19 pandemic 
casts in stark relief the limits of the ACA’s initial design as well 
as its steady erosion through legal challenges, implementation 
hurdles, executive orders, and partisan politics. The United States’ 
overreliance on ESI, limited public entitlements, and “Wild West” of 
an individual insurance market fail to serve the population’s health 
care needs under normal circumstances, not to mention a global 
pandemic and economic recession. 
One component of the ACA’s patchwork coverage strategy was 
expansion of public insurance, namely, Medicaid, to U.S. citizens 
and qualified non-citizens below 138% of the federal poverty 
level. But the U.S. Supreme Court later ruled that provision merely 
optional for states, resulting in 38 states (including Washington, 
D.C.) expanding Medicaid and 13 not expanding. Another strategy 
involved significant changes to the market for private health 
insurance, both ESI, the source of coverage for almost half of the 
country, and the individual and small-group insurance market, 
which historically has been fraught with limits, exclusions, and 
price distortions. The COVID-19 pandemic exposed key coverage 
gaps as well as long-standing inequities in health insurance and 
access to care. Those realities of the existing private insurance 
market presented numerous difficulties and considerable 
uncertainty for customers, including coverage for COVID testing 
and treatment, enrollment restrictions, and unexpected billing for 
out-of-pocket and out-of-network costs.
ACA Private Insurance Reforms
With respect to ESI, the ACA requires large employers (at least 
50 full-time-equivalent employees) to offer affordable, minimum-
value coverage to employees. Coverage is “affordable” if self-only 
coverage costs no more than roughly 10% of the employee’s 
household income. Coverage is “minimum-value” if the plan pays, 
on average, at least 60% of the cost of covered services. If an 
employer fails to offer such coverage to a requisite portion of its 
eligible workforce, it may be subject to an ACA tax penalty called a 
“shared responsibility” penalty. The shared responsibility penalty is 
triggered when an employee receives federally subsidized coverage 
through the ACA’s Health Insurance Marketplaces. Small employers 
are not subject to the shared responsibility penalty but may be 
eligible for tax subsidies or other assistance to extend coverage to 
their employees.
With respect to individual and small-group plans, the ACA 
dramatically overhauled both markets. Two of the key reforms 
include eliminating pre-existing condition exclusions and 
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disallowing premium-rate variation based on individual risk 
factors, with limited exceptions. Premium-rate variation 
means insurers may charge different premium rates based 
on geography (where the plan is sold), plan type (individual or 
family), age (with a premium variance no greater than 3 to 1), and 
tobacco use (with a premium variance no greater than 1.5 to 1). 
Those provisions are significant for COVID-19 coverage because 
they would seem to allow individuals and families to obtain 
coverage, without price gouging, even after being diagnosed or 
for the purpose of being tested. 
The Health Insurance Marketplaces are another critical component 
of the ACA’s statutory design to create a more accessible market 
for private health insurance. Marketplaces operate in each state 
and facilitate comparison among policies, enrollment, and access 
to federal subsidies. They may be operated by the state or the 
federal government. Marketplace plan enrollment is limited to 
certain times of the year, absent an applicable exception, as 
described more fully below. Consumers purchasing Marketplace 
plans are eligible, depending on income level, for two different 
types of federal subsidies. First, premium-assistance tax credits, 
which lower monthly premiums, and second, cost-sharing 
reduction (CSR) payments, which lower out-of-pocket costs for 
deductibles, co-insurance, and co-payments. 
Moreover, all non-group plans, both Marketplace and non-
Marketplace, must comply with the ACA’s broad coverage 
mandate, meaning that plans must offer a package of “essential 
health benefits” (EHB), defined by reference to state benchmark 
plans, which typically include acute inpatient care, urgent care, 
emergency room care, and outpatient care. The EHB requirement 
does not apply to ESI, but ESI plans are assumed to provide similar 
coverage, if not more. Indeed, the statute defines an EHB package 
by reference to benefits provided by a typical ESI plan.
Both Marketplace and ESI plans operate under annual Open 
Enrollment Periods, meaning they are available for enrollment only 
once a year, for a limited time period. Open Enrollment is subject 
to certain “life event” exceptions, such as losing health coverage, 
moving across state lines, getting married or divorced, having or 
adopting a child, becoming unemployed, or experiencing a death 
in the family. Those life events trigger Special Enrollment Periods 
(SEPs), which typically provide 60 days before or after the event 
to enroll. If the consumer misses the SEP window, she will have to 
wait until the next annual Open Enrollment Period to apply. These 
rules limit influx during the plan year, thereby helping insurers 
better predict costs and set premium rates. They have the effect, 
however, of preventing, or at least delaying, some consumers from 
accessing health insurance, even though they cannot be excluded 
based on preexisting conditions. In the COVID-19 context, that 
means that individuals without a qualifying life event, seeking 
insurance outside of the annual Open Enrollment period, would be 
out of luck.
Coverage Requirements and Out-of-Pocket Limits
Several ACA requirements apply to both ESI as well as individual 
and small-group plans. For one, plans must cover preventive care, 
such as screening, vaccinations, and well-child visits, without 
requiring co-payments, co-insurance, or deductibles, called “first-
dollar” coverage. Also, plans may not impose lifetime or annual 
caps on EHB and are subject to annual out-of-pocket cost limits 
on covered EHB, meaning all benefits after the limit is hit must be 
provided without cost-sharing. For 2020, the out-of-pocket limit 
is $8,150 for individual coverage and $16,300 for family policies. 
Although ESI plans are not required to cover EHB specifically, the 
EHB definition is relevant for applying these caps.
Figure 12.1. Estimated Coverage Types of People Losing Employee-Sponsored Health Insurance
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States may impose additional coverage or other requirements on 
individual and small-group plans. Those additional requirements, 
however, do not apply to self-insured ESI plans because of 
sweeping federal preemption provisions in the Employee 
Retirement Income Security Act of 1974 (ERISA). About 60% 
of people who receive insurance through employers are in 
self-insured plans, meaning that most ESI-insured individuals 
are in plans not subject to state regulation. That means that 
even if states enact broader COVID-19 coverage provisions or 
other consumer protections, a considerable number of insured 
individuals would not benefit from those reforms. An employer 
“self-insures” when it bears the financial risk of the medical claims 
rather than purchasing a group health plan for its employees. Many 
large employers opt for self-insuring, as it is less costly to directly 
pay for employees’ medical bills than to pay costly group premiums 
and underwrite state-mandated benefits. By contrast, under an 
“insured” ESI plan arrangement, the health insurer is the financial 
risk-bearer, and the employer pays premiums to the insurer on 
behalf of the entire group. 
Off-Marketplace and Non-ACA-Compliant Plans
In addition to ESI and Marketplace plans, individual and small-
group “off-Marketplace” plans are available. Off-Marketplace plans 
may be similarly comprehensive to other ESI but not eligible for 
federal premium-assistance or CSR subsidies. Effective with the 
2019 plan year, the tax penalty attached to the ACA’s individual 
health insurance mandate was zeroed out. That means there is 
no longer any penalty or sanction for failure to carry “minimum 
essential coverage” in the form of a comprehensive health plan. 
Accordingly, many people may choose not to purchase insurance at 
all or may opt for more loosely regulated, less comprehensive plans 
lacking the ACA’s signature consumer protections and coverage 
terms. For example, “catastrophic” plans typically have especially 
high deductibles and cost-sharing obligations without the ACA’s 
annual out-of-pocket limits, and short-term limited duration (STLD) 
plans may exclude coverage for pre-existing conditions and EHB, 
yet impose annual and lifetime limits. In the first quarter of 2019, 
an estimated 2.1 million individuals enrolled in off-Marketplace 
plans, and 1.1 individuals enrolled in non-ACA-compliant coverage. 
Although some states have responded with individual mandates, 
coverage mandates, or other measures to prevent proliferation 
of these substandard plans, individuals going into the COVID-19 
pandemic with those sorts of plans may find themselves with 
very limited coverage and very steep out-of-pocket costs before 
coverage kicks in.
Insurance Coverage for COVID-19 
Against that landscape, the COVID-19 pandemic presents a number 
of challenges for private insurance customers and plans, including 
coverage for testing and treatment, consumers’ exposure to out-
of-pocket or out-of-network costs, and enrollment limitations.
Coverage for Testing
One of the first questions regarding health insurance coverage for 
the COVID-19 pandemic concerns testing for the virus. The ACA’s 
“first-dollar” preventive care coverage requirement does not clearly 
encompass diagnostic testing, yet testing is essential for limiting 
disease spread by identifying infected individuals who should 
isolate themselves from healthy individuals. Private health plan 
cost-sharing requirements might deter individuals from getting 
tested, thereby undermining those public health strategies.
Congress acted quickly after the United States’ COVID-19 outbreak 
in spring 2020 to enact two bills containing provisions related 
to health insurance coverage. The Families First Coronavirus 
Response Act (FFCRA) and the Coronavirus Aid, Relief, and 
Economic Security (CARES) Act require all ACA-compliant and 
other comprehensive group and non-group health insurance 
plans to cover testing for detection or diagnoses of COVID-19 and 
the administration of that testing. FFCRA covers testing for both 
the active coronavirus infection as well as serological tests for 
the COVID-19 antibody. The coverage requirement only applies 
Figure 12.2: Uninsured Rates for the Nonelderly Population by Race and Ethnicity, 2010-2018. Source: Samantha Artiga & Kendal Orgera, Kaiser Family Foundation, 
2020
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during a federal public health emergency declaration, which HHS 
Secretary Alex M. Azar II initially declared January 27, 2020 and 
most recently renewed on April 26, 2020. The HHS Secretary may 
extend this public health emergency declaration for subsequent 
90 day periods, for as long as the COVID-19 public health 
emergency persists ).
Initially, coverage was limited under FFCRA to FDA-approved 
testing, but the CARES Act extends to (1) tests provided by clinical 
labs on an emergency basis (including public health labs); (2) state-
developed labs; and (3) tests for which the manufacturer says it 
will seek approval. Coverage also extends to any services or items 
provided during a medical visit that result in COVID-19 testing or 
screening. For example, if a patient is screened for influenza to rule 
out other causes of respiratory illness before the COVID-19 test is 
administered, the influenza test would be covered (Keith, 2020a).
The laws also specify that COVID-19-related diagnostic testing 
must be covered like other preventive care under the ACA, that 
is, without regard to deductibles, co-payments, co-insurance, 
preapproval, or precertification (Keith, 2020a). Under the CARES 
Act, plans are required to cover COVID-19 vaccines and other 
preventive measures on a first-dollar basis, starting 15 business 
days after the measure is approved. This requirement extends to all 
types of group health plans, including insured and self-insured ESI 
plans. The Departments of Labor, Treasury, and Health and Human 
Services’ guidance on FFCRA and CARES Act specifies that testing 
must be covered when furnished in traditional settings, including 
physicians’ offices, urgent care centers, and emergency rooms, as 
well as non-traditional settings, such as parking lots, football fields, 
and other public spaces.
The CARES Act addresses provider reimbursement for COVID-19 
diagnostic testing, requiring all comprehensive private health 
insurance plans to reimburse test providers based on the rate 
negotiated between the plan and the provider (i.e. the in-network 
rate). If there is no negotiated rate between the plan and provider 
(i.e. the provider is out-of-network), then the plan must fully 
reimburse the provider based on the provider’s own, publicly 
available “cash price” (Keith, 2020a).
Coverage for Treatment
Once an individual is infected with COVID-19 and experiencing acute 
symptoms, the next concern is coverage for treatment. These 
questions generally are resolved under the terms of the plan. ACA-
compliant plans both on and off the Marketplaces typically include 
such care under EHB. Likewise, comprehensive ESI plans typically 
cover treatment services. Since FFCRA and the CARES Act do not 
address COVID-19-related treatment costs, any applicable coverage 
limits and cost-sharing requirements would seem to apply (Pollitz, 
2020).
Consumers’ responsibility for treatment costs vary depending 
on their plans’ cost-sharing configurations, coverage terms, and 
provider networks. The ACA’s annual out-of-pocket limit provides 
some financial protection, but up until that point, consumers may 
face some unexpected out-of-pocket costs. While predictable out-
of-pocket costs include deductibles and co-payments, unexpected 
costs could arise from “surprise” medical bills, typically for out-of-
network care (Keith, 2020b). For example, if a hospital-employed 
anesthesiologist or an on-call emergency room doctor treats a 
patient even though that provider is not covered by the patient’s 
Figure 12.3: Percentage of Visits Leading to Surprise Out-of-Network Bills. Source: Christen Linke Young et al, USC-Brookings-Schaeffer on Health Policy, 2019.
ASSESSING LEGAL RESPONSES TO COVID-19   •   AUGUST 2020   •   WWW.COVID19POLICYPLAYBOOK.ORG   •   99
CHAPTER 12   •  PRIVATE INSURANCE LIMITS AND RESPONSES
plan, the provider may later bill the patient directly for the services 
at out-of-network rates. 
Surprise medical billing has been a focus of both state and 
federal legislative efforts since well before COVID-19. Analysis of 
emergency room visits covered by large employer plans found 
that 18% included at least one out-of-network charge. For non-
emergency stays at in-network hospitals and facilities, 16% 
involved at least one out-of-network claim (Pollitz, 2020).
While not addressed in the CARES Act explicitly, federal guidance 
implementing the Provider Relief Fund portion of the law suggests 
intent to prohibit surprise billing. One of the terms and conditions 
attached by the HHS to those relief funds stipulates that for all 
possible or actual cases of COVID-19, the provider (hospital, clinic, 
or physician practice) cannot charge more for out-of-pocket care 
than if the provider were in-network or had contracted with the 
patient’s insurance company (Keith, 2020b).
In addition to the above, rather obscure federal guidance, a handful 
of state insurance regulators have required or encouraged insurers 
to waive cost-sharing for COVID-19 testing and treatment (Norris, 
2020). In terms of state responses, New Mexico, for example, 
requires health plans to waive cost-sharing for medical services 
related to COVID-19, pneumonia, and influenza. Massachusetts 
requires health plans to provide COVID-19 treatment with no cost-
sharing, although the mandate is limited to care in a doctor’s office, 
urgent care clinic, or emergency room, and not the more expensive 
inpatient care. Vermont requires state-regulated health plans to 
waive cost-sharing for COVID-19 treatment. Minnesota initially 
issued guidance suggesting that insurers fully cover the cost of 
testing and limit or eliminate the cost of treatment, then also called 
for further state legislative response. In all cases, state cost-
sharing waivers do not apply to self-insured ESI plans due to ERISA 
preemption, as explained above.
In states where cost-sharing waivers are not required, a few private 
insurers have voluntarily issued waivers with varying policies. For 
example, some of these voluntary waivers apply to both in-network 
and out-of-network treatment, while others waive cost-sharing for 
any in-network treatment but only out-of-network emergencies. 
Most commonly, cost-sharing is waived only for in-network 
treatment, and in some cases, the waivers have date cut-offs or do 
not extend to self-insured ESI plans (Konrad, 2020).
Open Enrollment Periods
Although the ACA’s ban on preexisting condition exclusions would 
allow individuals who tested positive for COVID-19 to obtain 
coverage, open enrollment for Marketplace and most ESI plans 
had already concluded by the time COVID-19 became prevalent 
in the United States in spring 2020, and the federal government 
has not opened SEPs in response to the coronavirus pandemic 
(Norris, 2020). This means that uninsured individuals in states with 
federally-operated Marketplaces cannot enroll in coverage at this 
time unless they qualify for a standard SEP. Accordingly, many 
individuals who had not previously purchased health insurance 
have found themselves unable to obtain coverage during the 
pandemic.
U.S. Bureau of Labor Statistics data show that the unemployment 
rate jumped from 4.4% in March 2020 to a high of 14.7% (20.5 
million people) in April 2020, which is around the time that 
most states issued stay-at-home orders to prevent the virus 
Figure 12.4: Marketplace Special Enrollments Spiked Due to COVID-19. Source: Sara Hansard, Bloomberg Law, 2020.
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from spreading. Broken down by gender and race/ethnicity, the 
unemployment rate in April 2020 was 12.8% for white men, 15.8% 
for white women, 16.4% for Black men, 16.9% for Black women, 
16.7% for Latino men, and a whopping 20.2% for Latina women. As a 
result, the Department of Health and Human Services reported that 
487,000 people signed up for Marketplace plans after losing ESI 
coverage between January and June 2020, which is a 46% increase 
from the same time period in 2019 (Hansard, 2020b). In April 2020 
alone, Marketplace enrollment due to unemployment increased by 
139% compared to April 2019. 
By contrast, nearly all of the state-run health insurance 
Marketplaces opened SEPs – irrespective of qualifying life event – 
in response to the coronavirus pandemic. As of November 1, 2019, 
13 states have been operating their own Marketplaces, and all of 
them except Idaho reopened their Marketplaces to allow uninsured 
individuals to enroll in ACA-compliant health plans (Norris, 2020). 
Still, SEP enrollment periods and effective coverage dates vary by 
state, and all except for Vermont (enroll by August 14, 2020) and the 
District of Columbia (enroll by September 15, 2020) have already 
closed. 
SEPs triggered by the coronavirus pandemic are designed to let 
uninsured people gain coverage; they do not allow people with 
health insurance to switch to different plans. Some non-ACA-
compliant health plans, such as STLD, farm-bureau-issued, or 
health care sharing ministry plans, are not required to cover 
COVID-19 testing, but enrollees in those plans would be deemed 
uninsured for purposes of obtaining access to SEPs or possibly 
Medicaid (Norris, 2020). 
Another option for the recently unemployed may be to retain 
coverage through the Consolidated Omnibus Budget Reconciliation 
Act of 1985 (COBRA). COBRA is a long-standing option for former 
employees to maintain ESI coverage, allowing them to retain 
access to the same comprehensive plan, provider network, 
and negotiated group rate for up to 36 months. The downside 
is that COBRA requires former employees to pay not only their 
contribution, but also the employers’ prior contribution toward the 
premium, plus a 2% administration fee. In 2019, the average cost of 
ESI in terms of annual premiums was $7,188 for single coverage and 
$20,576 for family coverage. While the individual was employed, 
the employer might have paid 80% of that premium for individual 
coverage and 70% for family coverage (Gangopadhyaya & Garret, 
2020). As a result, COBRA coverage is unaffordable for many, 
especially after losing income from a job.
In prior economic emergencies, Congress authorized subsidies 
for employees to keep their job-based coverage after being laid 
off. According to the Treasury Department, COBRA subsidies 
from the 2009 stimulus package were “especially important for 
maintaining health insurance coverage for middle-class families 
during the recession” (Keith, 2020a). While laid-off workers will 
qualify for SEPs in both state- and federally-operated Marketplaces, 
potentially with subsidies, COBRA subsidies could help workers and 
their families maintain continued access to their providers and limit 
gaps in coverage. 
